PTC Therapeutics, Inc. (PTCT) Return on equity 2016–2021
PTC Therapeutics, Inc. (PTCT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-36432.6%FY2021 · since FY2016: -118.8% → -36432.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -36432.6% | -36341.7 pp |
| FY2020 | -90.9% | -48.6 pp |
| FY2019 | -42.3% | -5.8 pp |
| FY2018 | -36.5% | +14.0 pp |
| FY2017 | -50.5% | +68.3 pp |
| FY2016 | -118.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PTCT financial trends
PTCT RevenuePTCT Net incomePTCT Net marginPTCT Gross profitPTCT Gross marginPTCT Operating incomePTCT Operating marginPTCT Operating cash flowPTCT Free cash flowPTCT Capital expendituresPTCT Stock buybacksPTCT Dividends paidPTCT Total assetsPTCT Total liabilitiesPTCT Shareholders’ equityPTCT overview →